TEARLAB CORP (OTCMKTS:TEAR)’s Stock Is Buy After Less Market Selling

April 16, 2018 - By Jacob Falcon

TearLab Corporation (OTCMKTS:TEAR) Logo

The stock of TEARLAB CORP (OTCMKTS:TEAR) registered a decrease of 70.51% in short interest. TEAR’s total short interest was 4,600 shares in April as published by FINRA. Its down 70.51% from 15,600 shares, reported previously. The short interest to TEARLAB CORP’s float is 0.09%.

The stock decreased 1.48% or $0.004 during the last trading session, reaching $0.266. About 6,337 shares traded. TearLab Corporation (OTCMKTS:TEAR) has declined 89.76% since April 16, 2017 and is downtrending. It has underperformed by 101.31% the S&P500.

TearLab Corporation operates as an in-vitro diagnostic firm in the United States. The company has market cap of $2.72 million. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. It currently has negative earnings. The company??s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.